Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes Other Scholarly Work

Kotecha, Rupesh, Mehta, Minesh P. (2020). Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes . NEURO-ONCOLOGY, 22(8), 1062-1064. 10.1093/neuonc/noaa133

Open Access

keywords

  • BEVACIZUMAB
  • Clinical Neurology
  • LYMPHOPENIA
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • PHASE-II
  • RADIATION-THERAPY
  • Science & Technology
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 1062

end page

  • 1064

volume

  • 22

issue

  • 8